Intouch VP of Strategic Planning, Jeff Greene weighs in on what changes we might see in marketing strategies as biosimilar marketers look to compete with biologics.
Related Posts
08|16|21
EVERSANA INTOUCH Recognized as a Finalist in the 2024 Manny Awards
Intouch VP of Strategic Planning, Jeff Greene weighs in on what changes we might see in marketing strategies as biosimilar marketers look to compete with biologics.
08|16|21
Branding in the Digital Age: Q&A with Justin Chase
Intouch VP of Strategic Planning, Jeff Greene weighs in on what changes we might see in marketing strategies as biosimilar marketers look to compete with biologics.
08|16|21
Privacy on Social Comes With a Price: How Subscriptions Are Changing the Way We Consume and Advertise on Social Media
Intouch VP of Strategic Planning, Jeff Greene weighs in on what changes we might see in marketing strategies as biosimilar marketers look to compete with biologics.